PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403525
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403525
Heart Failure POC And LOC Devices Market Forecasts to 2030 - Global Analysis By Test Type, Technology, End User and by Geography
According to Stratistics MRC, the Global Heart Failure POC and LOC Devices Market is accounted for $97.62 million in 2023 and is expected to reach $327.94 million by 2030 growing at a CAGR of 18.9% during the forecast period. Devices known as point-of-care (POC) and lab-on-a-chip (LOC) have become revolutionary in the treatment of heart failure. Healthcare providers can perform on-the-spot testing with these portable, rapid diagnostic technologies, giving them quick insights into a patient's cardiac health. POC devices, which provide quick and effective diagnostics at the patient's bedside or in primary care settings, include handheld ultrasound devices, portable cardiac biomarker analyzers, and miniaturized lab-on-a-chip platforms.
According to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths).
Market Dynamics:
Driver:
Growing heart failure rates
The market for POC and LOC devices is primarily driven by the rising incidence of heart failure, which is linked to aging populations, sedentary lifestyles, and the mounting burden of cardiovascular risk factors. Additionally, globally, the prevalence of heart failure is increasing, which raises the need for diagnostic instruments that can quickly and accurately evaluate cardiac function and support prompt and efficient treatment plans.
Restraint:
Budgetary restrictions and accessibility
The financial limitations pertaining to POC and LOC devices comprise not only the initial acquisition costs but also continuous expenditures like consumables, maintenance, and calibration. Furthermore, patients and healthcare facilities alike are concerned about affordability, especially in environments with limited resources. These advanced diagnostic tools come with a high upfront cost, which could prevent them from being widely adopted, restrict accessibility, and affect how cost-effectively healthcare is delivered.
Opportunity:
Extension of diagnostic expertise
There are numerous opportunities to increase the diagnostic capabilities that POC and LOC devices offer. Sustained technological progress, specifically in domains like biosensors, micro fluidics, and nanotechnology, offers prospects for augmenting the sensitivity and specificity of said apparatus. Moreover, healthcare practitioners can now obtain a deeper and more comprehensive understanding of cardiovascular health thanks to advancements in multiplexed testing and the integration of novel biomarkers.
Threat:
Strong market rivalry
The POC and LOC device market is highly competitive, which poses risks like price pressure, market saturation, and difficulty differentiating products. The pressure to compete is increased by new entrants and ongoing technological advancements. Furthermore, in order to stay competitive, businesses need to make investments in R&D, put effective marketing strategies into practice, and concentrate on developing distinctive value propositions in order to hold onto their market positions and continue growing.
COVID-19 Impact:
The COVID-19 pandemic has had a significant effect on the market for medical diagnostics, particularly point-of-care (POC) and lab-on-a-chip (LOC) devices. Demand for POC and LOC devices has surged due to the pressing need for quick and decentralized testing solutions, especially in the diagnosis of COVID-19. These technological advancements have been essential in improving test accessibility and facilitating prompt results at the point of care. On the other hand, the pandemic has also brought about difficulties like changes in the distribution of healthcare resources, heightened competition, and supply chain disruptions. Moreover, the management of the pandemic has spurred innovation and highlighted the critical role POC and LOC devices play in flexible, decentralized healthcare systems, which will impact the market's future direction in the aftermath of the pandemic.
The Genomic Testing segment is expected to be the largest during the forecast period
The segment of the heart failure POC and LOC devices market that is expected to hold the largest share is genomic testing. A person's DNA is analyzed as part of a genomic test to find genetic variants, mutations, and disease predispositions. The broad applications of this segment in pharmacogenomics, oncology, rare genetic disorders, and personalized medicine have made it more well-known. In order to diagnose, treat, and evaluate disease risk, genomic testing is essential. This results in more specialized and efficient healthcare interventions. Additionally, genomic testing is becoming increasingly popular and is becoming recognized as a major player in the field of molecular diagnostics due to the ongoing improvements in sequencing technologies and the growing knowledge of the genetic causes of various diseases.
The Home Care segment is expected to have the highest CAGR during the forecast period
In the market for heart failure POC and LOC devices, the home care segment is growing at the highest CAGR. Patients receiving home care services receive medical attention, supervision, and support in the comfort of their own homes. A number of factors, such as an aging population, a desire for individualized and patient-centered care, and developments in remote monitoring technologies, have contributed to the rise in demand for home care. In addition to providing patients with convenience, home care services lower healthcare costs by minimizing hospital stays. Moreover, the COVID-19 pandemic has expedited the uptake of home care services as individuals pursue less hazardous substitutes for in-person medical consultations.
Region with largest share:
It is projected that the heart failure POC and LOC device market will have the largest share in the North American region. This is ascribed to elements like high healthcare spending, sophisticated healthcare infrastructure, a solid regulatory base, and a strong emphasis on R&D. With a large healthcare industry footprint, the United States in particular is a major factor contributing to the region's dominance. Furthermore, North America gains from a focus on healthcare accessibility, technological innovation, and an aging population.
Region with highest CAGR:
The market for heart failure POC and LOC devices is growing at the highest CAGR in the Asia-Pacific region. Growing healthcare awareness, rising disposable incomes, growing healthcare infrastructure, and an aging and sizable population are some of the factors driving this explosive growth. Significant investments in healthcare services and technology are being made in APAC nations like China and India, along with encouraging government initiatives. Additionally, the demand for cutting-edge medical treatments and the rising incidence of chronic diseases both support the strong growth in the Asia-Pacific healthcare market.
Key players in the market:
Some of the key players in Heart Failure POC and LOC Devices market include Instrumentation Laboratory Company, F. Hoffmann-La Roche Ltd, Abaxis, Inc., Jant Pharmacal Corporation, Danaher Corporation, Siemens Healthineers, Trinity Biotech, Quidel Corporation, Abbott and bioMerieux S.A.
Key Developments:
In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.
In December 2023, Danaher Corp., a global life sciences and diagnostics provider based in Washington D.C., has completed its $5.7 billion acquisition of Abcam plc, a supplier of protein research tools for life sciences based in Cambridge, England. Abcam has become an indirect wholly owned subsidiary of Danaher. Danaher's Life Sciences businesses provide tools and technologies to support the advancement of pharmaceuticals and biopharmaceuticals.
In November 2023, Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
Test Types Covered:
- Proteomic Testing
- Metabolomic Testing
- Genomic Testing
- Other Test Types
Technologies Covered:
- Microfluidics
- Array-based Systems
- Other Technologies
End Users Covered:
- Clinics & Hospitals
- Home Care
- Assisted Living Healthcare Facilities
- Laboratory
- Specialty Centers
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Heart Failure POC And LOC Devices Market, By Test Type
- 5.1 Introduction
- 5.2 Proteomic Testing
- 5.3 Metabolomic Testing
- 5.4 Genomic Testing
- 5.5 Other Test Types
6 Global Heart Failure POC And LOC Devices Market, By Technology
- 6.1 Introduction
- 6.2 Microfluidics
- 6.3 Array-based Systems
- 6.4 Other Technologies
7 Global Heart Failure POC And LOC Devices Market, By End User
- 7.1 Introduction
- 7.2 Clinics & Hospitals
- 7.3 Home Care
- 7.4 Assisted Living Healthcare Facilities
- 7.5 Laboratory
- 7.6 Specialty Centers
- 7.7 Other End Users
8 Global Heart Failure POC And LOC Devices Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Instrumentation Laboratory Company
- 10.2 F. Hoffmann-La Roche Ltd
- 10.3 Abaxis, Inc.
- 10.4 Jant Pharmacal Corporation
- 10.5 Danaher Corporation
- 10.6 Siemens Healthineers
- 10.7 Trinity Biotech
- 10.8 Quidel Corporation
- 10.9 Abbott
- 10.10 bioMerieux S.A
List of Tables
- Table 1 Global Heart Failure POC And LOC Devices Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
- Table 3 Global Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
- Table 4 Global Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
- Table 5 Global Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
- Table 6 Global Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 7 Global Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
- Table 8 Global Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
- Table 9 Global Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
- Table 10 Global Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 11 Global Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 12 Global Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
- Table 13 Global Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
- Table 14 Global Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
- Table 15 Global Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
- Table 16 Global Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
- Table 17 Global Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 18 North America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 19 North America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
- Table 20 North America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
- Table 21 North America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
- Table 22 North America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
- Table 23 North America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 24 North America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
- Table 25 North America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
- Table 26 North America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
- Table 27 North America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 28 North America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 29 North America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
- Table 30 North America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
- Table 31 North America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
- Table 32 North America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
- Table 33 North America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
- Table 34 North America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 35 Europe Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 36 Europe Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
- Table 37 Europe Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
- Table 38 Europe Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
- Table 39 Europe Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
- Table 40 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 41 Europe Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
- Table 42 Europe Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
- Table 43 Europe Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
- Table 44 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 45 Europe Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 46 Europe Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
- Table 47 Europe Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
- Table 48 Europe Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
- Table 49 Europe Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
- Table 50 Europe Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
- Table 51 Europe Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 52 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 53 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
- Table 54 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
- Table 55 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
- Table 56 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
- Table 57 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 58 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
- Table 59 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
- Table 60 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
- Table 61 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 62 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 63 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
- Table 64 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
- Table 65 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
- Table 66 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
- Table 67 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
- Table 68 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 69 South America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 70 South America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
- Table 71 South America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
- Table 72 South America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
- Table 73 South America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
- Table 74 South America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 75 South America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
- Table 76 South America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
- Table 77 South America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
- Table 78 South America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 79 South America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 80 South America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
- Table 81 South America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
- Table 82 South America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
- Table 83 South America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
- Table 84 South America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
- Table 85 South America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 86 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 87 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
- Table 88 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
- Table 89 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
- Table 90 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
- Table 91 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 92 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
- Table 93 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
- Table 94 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
- Table 95 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 96 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 97 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
- Table 98 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
- Table 99 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
- Table 100 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
- Table 101 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
- Table 102 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
